Latest Posts Under: Pharma Industry News

ExeGi Pharma announces probiotic Visbiome clinical trial in MS patients

Visbiome clinical trial : ExeGi Pharma said that researchers at Columbia University Irving Medical Center and the University of Pittsburgh will be studying the company’s probiotic product Visbiome in multiple sclerosis (MS) patients in a new clinical trial. The clinical trial will look into the effects of probiotics on the gut microbiota and immune systems […]

The post ExeGi Pharma announces probiotic Visbiome clinical trial in MS patients appeared first on PharmaNewsDaily.com.

Equashield CSTD now available for oncology nurses in Japan

US medical device company Equashield through Japanese distributor Tosho has entered into an exclusive agreement with IV tube manufacturer PAL Medical to provide Equashield’s Closed System Transfer Devices (CSTDs) to oncology nurses in Japan. Post agreement, Tosho will provide PAL Medical with Equashield’s closed IV connectors to develop safer IV sets for oncology nurses administering […]

The post Equashield CSTD now available for oncology nurses in Japan appeared first on PharmaNewsDaily.com.

Boehringer Ingelheim bags Ofev FDA approval for SSc-ILD

Ofev FDA approval for SSc-ILD : The US Food and Drug Administration (FDA) has extended approval for Boehringer Ingelheim Pharmaceuticals’ Ofev (nintedanib) capsules for the treatment of a particular condition associated with systemic sclerosis or scleroderma. The latest FDA approval for Ofev is for its use in slowing the rate of decline in pulmonary function […]

The post Boehringer Ingelheim bags Ofev FDA approval for SSc-ILD appeared first on PharmaNewsDaily.com.

Maruho, X-Chem collaborate to advance drug discovery

X-Chem, a US biotech company, has entered into a drug discovery partnership with Japanese dermatology company Maruho to discover lead compounds for new and difficult targets for the treatment of human ailments. Post agreement, X-Chem will use its DNA-encoded library (DEX) screening platform to search for novel drug-like leads for Maruho targets associated with human […]

The post Maruho, X-Chem collaborate to advance drug discovery appeared first on PharmaNewsDaily.com.

OncoCyte to acquire Razor Genomics to advance lung cancer diagnosis

OncoCyte acquisition of Razor Genomics : US diagnostic tests developer OncoCyte has agreed to acquire Razor Genomics, a provider of molecular diagnostic testing services for lung cancer. Initially, the diagnostic tests developer will acquire an initial 25% equity interest in the form of the Razor Genomics’ preferred stock for $10 million. After closing of the […]

The post OncoCyte to acquire Razor Genomics to advance lung cancer diagnosis appeared first on PharmaNewsDaily.com.

Khiron begins construction on medical cannabis production plant in Uruguay

Khiron Life Sciences, a Canadian cannabis producer, has begun the construction on a new medical cannabis production plant in Uruguay, thereby expanding multi-jurisdiction and export capacity. The new cannabis cultivation and processing facility is located in Juan Lacaze. The medical cannabis production plant with a production capacity of 17 tons per year will increase Khiron […]

The post Khiron begins construction on medical cannabis production plant in Uruguay appeared first on PharmaNewsDaily.com.

Researchers develop new AI-driven model for drug discovery

Researchers at the University of Cambridge have developed a new artificial intelligence (AI) algorithm, which can predict the complex chemical reactions outcomes with more than 90% accuracy and facilitate the drug discovery by suggesting ways to make complex molecules. Providing the chemical ‘map’ to the desired destination, the new algorithm also shows chemists how to […]

The post Researchers develop new AI-driven model for drug discovery appeared first on PharmaNewsDaily.com.

Mobile health devices could detect common heart condition atrial fibrillation, says study

Mobile health (mHealth) devices could help screen and detect a common heart condition atrial fibrillation (AF), according to the new study. Atrial fibrillation is a heart rhythm disturbance, affecting around one million people in the UK. People with atrial fibrillation are at increased risk of having a stroke and dying, as well as heart failure […]

The post Mobile health devices could detect common heart condition atrial fibrillation, says study appeared first on PharmaNewsDaily.com.

Vertex to acquire Semma Therapeutics to advance stem cell-based treatments for type 1 diabetes

Vertex acquisition of Semma Therapeutics : US biotechnology company Vertex Pharmaceuticals has agreed to acquire privately-held biotechnology company Semma Therapeutics for $950 million in cash, as per the latest pharma acquisition news. Both the pharma companies are based in Massachusetts. Post-acquisition, Vertex Pharmaceuticals will advance curative cell-based treatments of Semma Therapeutics for type 1 diabetes and […]

The post Vertex to acquire Semma Therapeutics to advance stem cell-based treatments for type 1 diabetes appeared first on PharmaNewsDaily.com.

Puma secures FDA orphan drug status for NERLYNX in breast cancer with brain metastases

US biotech company Puma Biotechnology has secured orphan drug designation to NERLYNX (neratinib) from the US Food and Drug Administration (FDA) for the treatment of breast cancer patients having brain metastases, as per the latest pharma regulatory news. The FDA orphan drug designation program is given to investigational drugs designed for the treatment, prevention, or […]

The post Puma secures FDA orphan drug status for NERLYNX in breast cancer with brain metastases appeared first on PharmaNewsDaily.com.

Scroll To Top